Tag Archives: ribavirin

April, 2016

  • 25 April

    FDA Expands Approval of AbbVie’s Viekira Pak for Use without RBV

    NORTH CHICAGO, Ill., April 25, 2016 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the use of VIEKIRA PAK® (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) without ribavirin (RBV) in …